Ab­b­Vie un­veils di­ver­si­ty, cli­mate and ac­ces­si­bil­i­ty strate­gies in new re­port

All eyes are on Ab­b­Vie. The com­pa­ny’s round­ing out its first decade on Wall Street this year, and over the next five, it’s pre­dict­ed to beat out Pfiz­er to be­come the world’s top-sell­ing phar­ma gi­ant.

But it isn’t just about sales. More and more phar­ma com­pa­nies are pub­lish­ing re­ports to out­line cli­mate, so­ci­etal, and even pric­ing goals.  Last week, Ab­b­Vie laid out its strat­e­gy in its lat­est En­vi­ron­ment, So­cial & Gov­er­nance (ESG) re­port.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER